NDC 17163-016 - API GENERAL CURE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17163-016
- Package NDCs from labels
- 17163-016-17
- Manufacturer
- MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited
- Effective date
- 2026-04-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PRAZIQUANTEL - MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited | MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited | 2026-04-21 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17163-016-17 | API GENERAL CURE | 850 g in 1 JAR | POWDER | 850 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals, Inc. | 4040db14-750f-6d20-e054-00144ff8d46c | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Major Pharmaceuticals | 71f5ce2f-17f8-45fc-b27d-2bf982591ab3 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| PRAZIQUANTEL | PRAZIQUANTEL | Par Health USA, LLC | 16f2b9c4-a260-4a31-bd52-e5945913246c | 2026-08-12 | Warnings, Adverse reactions | 6490C9U457 |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 5cc3fd98-d579-432e-a4b5-b6d5586991a6 | 2026-08-05 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | dc28753c-95ec-4b41-ad77-c4a66698d9db | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | b49a8ad0-2cf9-4386-8bf5-1b1df87b0022 | 2026-08-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | d5784eeb-6b99-4e8a-847b-b0d1090ed48a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 2f7d84d4-1085-4243-be88-442eecb85205 | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Vagizole | METRONIDAZOLE | iNutrition LLC | fd5e884b-cf07-493b-bb93-039bbb0c4784 | 2026-07-22 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 5cf3cc1f-601e-4997-bfb2-a573c31c8189 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Sun Pharmaceutical Industries, Inc. | 4a233572-2471-4e99-a45e-2de978abcf16 | 2026-07-15 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Sun Pharmaceutical Industries, Inc. | 5a504f74-bccd-433a-bd5b-6822f98c34df | 2026-07-15 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Sun Pharmaceutical Industries, Inc. | 5842a554-58d1-4ee4-99aa-1e6029a69be2 | 2026-07-15 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 4748ba37-9d66-497d-aa9f-ca2d541c5f41 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Preferred Pharmaceuticals Inc. | 59e53582-244a-4e9d-b18e-75dddc6a5052 | 2026-07-08 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | cfeab9e3-58b9-4890-9185-11b62904e2af | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Preferred Pharmaceuticals Inc. | cbee69e8-029c-49d2-89cd-f504b8e0ac28 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Preferred Pharmaceuticals Inc. | 3e0a14f1-961b-4722-bfea-aafcc5d7706c | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 53918705-d2fe-4c6b-9501-a619a8ad3991 | 2026-07-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Kanchan Healthcare Inc | 8836334e-6db4-44be-bc9e-099b26322cf4 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.